$AMLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMYLIN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMYLIN PHARMACEUTICALS INC. Get notifications about new insider transactions in AMYLIN PHARMACEUTICALS INC for free.
Page: < prev 1 ... 11 12 13 14 15 16 17 18 18 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 6.88 | 2,772 | 19,058 | 113,282 | 110.5 K to 113.3 K (+2.51 %) |
Oct 17 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 3,333 | 19,098 | 10,457 | |
Oct 17 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Sell | S | 36.40 | 3,333 | 121,321 | 26,498 | 29.8 K to 26.5 K (-11.17 %) |
Oct 17 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 3,333 | 19,098 | 29,831 | 26.5 K to 29.8 K (+12.58 %) |
Oct 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 36.10 | 3,846 | 138,835 | 1,867,750 | 1.9 M to 1.9 M (-0.21 %) |
Oct 17 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Sell | S | 36.26 | 12,500 | 453,206 | 1,079,208 | 1.1 M to 1.1 M (-1.14 %) |
Oct 11 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 34.13 | 3,846 | 131,269 | 1,871,596 | 1.9 M to 1.9 M (-0.21 %) |
Oct 11 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 34.75 | 2,000 | 69,500 | 481 | 2.5 K to 481 (-80.61 %) |
Oct 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.31 | 2,000 | 626 | 73,540 | |
Oct 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.31 | 5,000 | 1,565 | 75,540 | |
Oct 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 34.90 | 2,000 | 69,800 | 110,510 | 112.5 K to 110.5 K (-1.78 %) |
Oct 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.31 | 2,000 | 626 | 112,510 | 110.5 K to 112.5 K (+1.81 %) |
Oct 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 35.85 | 5,000 | 179,250 | 110,510 | 115.5 K to 110.5 K (-4.33 %) |
Oct 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.31 | 5,000 | 1,565 | 115,510 | 110.5 K to 115.5 K (+4.52 %) |
Oct 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,500 | 13,975 | 35,000 | |
Oct 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 36.15 | 2,500 | 90,377 | 12,600 | 15.1 K to 12.6 K (-16.56 %) |
Oct 04 2005 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,500 | 13,975 | 15,100 | 12.6 K to 15.1 K (+19.84 %) |
Oct 07 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | M | 5.73 | 4,375 | 25,069 | 0 | |
Oct 07 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Payment of Exercise | F | 35.56 | 704 | 25,034 | 26,498 | 27.2 K to 26.5 K (-2.59 %) |
Oct 07 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Buy | M | 5.73 | 4,375 | 25,069 | 27,202 | 22.8 K to 27.2 K (+19.17 %) |
Oct 03 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 2.91 | 2,000 | 5,812 | 6,256 | |
Oct 03 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 34.90 | 2,000 | 69,800 | 110,510 | 112.5 K to 110.5 K (-1.78 %) |
Oct 03 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 2.91 | 2,000 | 5,812 | 112,510 | 110.5 K to 112.5 K (+1.81 %) |
Oct 03 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Sell | S | 34.48 | 12,500 | 431,038 | 1,091,708 | 1.1 M to 1.1 M (-1.13 %) |
Sep 20 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Sell | S | 30.10 | 12,500 | 376,308 | 1,104,208 | 1.1 M to 1.1 M (-1.12 %) |
Sep 27 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 31.59 | 3,846 | 121,485 | 1,875,442 | 1.9 M to 1.9 M (-0.20 %) |
Sep 22 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Gift | G | 0.00 | 250 | 0 | 110,510 | 110.8 K to 110.5 K (-0.23 %) |
Sep 22 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Gift | G | 0.00 | 150 | 0 | 51,195 | 51.3 K to 51.2 K (-0.29 %) |
Sep 13 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 31.29 | 3,846 | 120,350 | 1,879,288 | 1.9 M to 1.9 M (-0.20 %) |
Sep 13 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Sell | J | 31.16 | 5,000 | 155,800 | 118,303 | 123.3 K to 118.3 K (-4.06 %) |
Sep 13 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Buy | J | 31.16 | 1,000 | 31,160 | 1,116,708 | 1.1 M to 1.1 M (+0.09 %) |
Sep 13 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Gift | G | 0.00 | 500 | 0 | 1,115,708 | 1.1 M to 1.1 M (-0.04 %) |
Sep 13 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Gift | G | 0.00 | 3,000 | 0 | 1,116,208 | 1.1 M to 1.1 M (-0.27 %) |
Sep 13 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Option Exercise | M | 6.88 | 9,005 | 61,909 | 0 | |
Sep 13 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Buy | M | 6.88 | 9,005 | 61,909 | 51,345 | 42.3 K to 51.3 K (+21.27 %) |
Sep 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 31.75 | 2,000 | 63,500 | 2,481 | 4.5 K to 2.5 K (-44.63 %) |
Sep 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 933 | 6,706 | 21,184 | |
Sep 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 32.72 | 933 | 30,523 | 9,186 | 10.1 K to 9.2 K (-9.22 %) |
Sep 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 933 | 6,706 | 10,119 | 9.2 K to 10.1 K (+10.16 %) |
Sep 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 2.91 | 2,000 | 5,812 | 8,256 | |
Sep 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 2.91 | 3,000 | 8,718 | 10,256 | |
Sep 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 32.78 | 2,000 | 65,560 | 110,760 | 112.8 K to 110.8 K (-1.77 %) |
Sep 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 2.91 | 2,000 | 5,812 | 112,760 | 110.8 K to 112.8 K (+1.81 %) |
Sep 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 32.78 | 3,000 | 98,340 | 110,760 | 113.8 K to 110.8 K (-2.64 %) |
Sep 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 2.91 | 3,000 | 8,718 | 113,760 | 110.8 K to 113.8 K (+2.71 %) |
Aug 31 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 31.87 | 3,846 | 122,588 | 1,883,134 | 1.9 M to 1.9 M (-0.20 %) |
Aug 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 14.38 | 2,000 | 28,750 | 2,064 | |
Aug 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 30.34 | 2,000 | 60,680 | 110,760 | 112.8 K to 110.8 K (-1.77 %) |
Aug 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 14.38 | 2,000 | 28,750 | 112,760 | 110.8 K to 112.8 K (+1.81 %) |
Aug 16 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 20.19 | 3,846 | 77,651 | 1,886,980 | 1.9 M to 1.9 M (-0.20 %) |
Aug 24 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 14.38 | 3,000 | 43,125 | 4,064 | |
Aug 24 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 27.70 | 3,000 | 83,100 | 110,760 | 113.8 K to 110.8 K (-2.64 %) |
Aug 24 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 14.38 | 3,000 | 43,125 | 113,760 | 110.8 K to 113.8 K (+2.71 %) |
Aug 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 20.01 | 2,000 | 40,020 | 4,481 | 6.5 K to 4.5 K (-30.86 %) |
Aug 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 933 | 6,706 | 22,117 | |
Aug 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 18.91 | 933 | 17,643 | 9,186 | 10.1 K to 9.2 K (-9.22 %) |
Aug 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 933 | 6,706 | 10,119 | 9.2 K to 10.1 K (+10.16 %) |
Aug 02 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 20.00 | 3,846 | 76,920 | 1,890,826 | 1.9 M to 1.9 M (-0.20 %) |
Jul 18 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 21.85 | 3,846 | 84,025 | 1,894,672 | 1.9 M to 1.9 M (-0.20 %) |
Jul 08 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 20.50 | 1,500 | 30,750 | 6,481 | 8 K to 6.5 K (-18.79 %) |
Jul 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 160 | 0 | 3,724 | |
Jul 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 300 | 0 | 3,564 | |
Jul 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | TESTMAN THOMAS R | Director | Option Exercise | A | 0.00 | 580 | 0 | 4,439 | |
Jul 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | A | 0.00 | 410 | 0 | 2,685 | |
Jul 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 0.00 | 350 | 0 | 2,653 | |
Jul 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREGG TERRANCE H | Director | Option Exercise | A | 0.00 | 350 | 0 | 2,894 | |
Jul 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 410 | 0 | 3,234 | |
Jul 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 21.13 | 3,846 | 81,266 | 1,898,518 | 1.9 M to 1.9 M (-0.20 %) |
Jul 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRYSON VAUGHN D | Director | Option Exercise | A | 0.00 | 460 | 0 | 3,980 | |
Jul 05 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 933 | 6,706 | 23,050 | |
Jul 05 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 20.88 | 933 | 19,481 | 8,271 | 9.2 K to 8.3 K (-10.14 %) |
Jul 05 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 933 | 6,706 | 9,204 | 8.3 K to 9.2 K (+11.28 %) |
Jun 27 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Gift | G | 0.00 | 100 | 0 | 7,981 | 8.1 K to 8 K (-1.24 %) |
Jun 22 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 20.45 | 3,846 | 78,653 | 1,902,364 | 1.9 M to 1.9 M (-0.20 %) |
Jun 20 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 20.40 | 3,846 | 78,473 | 1,906,210 | 1.9 M to 1.9 M (-0.20 %) |
Jun 16 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 1,766 | 12,693 | 23,983 | |
Jun 16 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 100 | 719 | 25,749 | |
Jun 16 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 19.05 | 1,766 | 33,642 | 8,271 | 10 K to 8.3 K (-17.59 %) |
Jun 16 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 1,766 | 12,693 | 10,037 | 8.3 K to 10 K (+21.35 %) |
Jun 16 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 19.00 | 100 | 1,900 | 8,271 | 8.4 K to 8.3 K (-1.19 %) |
Jun 16 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 100 | 719 | 8,371 | 8.3 K to 8.4 K (+1.21 %) |
Jun 16 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Sell | S | 18.64 | 24,000 | 447,271 | 1,119,000 | 1.1 M to 1.1 M (-2.10 %) |
Jun 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Option Exercise | M | 6.75 | 60,000 | 405,000 | 0 | |
Jun 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Option Exercise | M | 6.75 | 40,000 | 270,000 | 0 | |
Jun 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Payment of Exercise | F | 15.05 | 12,061 | 181,518 | 1,143,000 | 1.2 M to 1.1 M (-1.04 %) |
Jun 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Payment of Exercise | F | 15.05 | 26,910 | 404,996 | 1,155,061 | 1.2 M to 1.2 M (-2.28 %) |
Jun 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Buy | M | 6.75 | 60,000 | 405,000 | 1,181,971 | 1.1 M to 1.2 M (+5.35 %) |
Jun 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Payment of Exercise | F | 15.05 | 8,040 | 121,002 | 1,121,971 | 1.1 M to 1.1 M (-0.71 %) |
Jun 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Payment of Exercise | F | 15.05 | 17,940 | 269,997 | 1,130,011 | 1.1 M to 1.1 M (-1.56 %) |
Jun 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Buy | M | 6.75 | 40,000 | 270,000 | 1,147,951 | 1.1 M to 1.1 M (+3.61 %) |
Jun 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Option Exercise | M | 5.73 | 1,874 | 10,738 | 0 | |
Jun 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Buy | M | 5.73 | 1,874 | 10,738 | 211,269 | 209.4 K to 211.3 K (+0.89 %) |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | J | 16.23 | 12,000 | 194,760 | 12,000 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | TESTMAN THOMAS R | Director | Option Exercise | J | 16.23 | 12,000 | 194,760 | 12,000 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | J | 16.23 | 12,000 | 194,760 | 12,000 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | J | 16.23 | 12,000 | 194,760 | 12,000 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREGG TERRANCE H | Director | Option Exercise | J | 16.23 | 12,000 | 194,760 | 12,000 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | J | 16.23 | 12,000 | 194,760 | 12,000 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRYSON VAUGHN D | Director | Option Exercise | J | 16.23 | 12,000 | 194,760 | 12,000 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Option Exercise | A | 16.54 | 35,475 | 586,757 | 35,475 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Option Exercise | A | 16.54 | 4,525 | 74,844 | 4,525 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | A | 16.54 | 34,749 | 574,748 | 34,749 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | A | 16.54 | 5,251 | 86,852 | 5,251 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical Affa ... | Option Exercise | A | 16.54 | 58,838 | 973,181 | 58,838 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical Affa ... | Option Exercise | A | 16.54 | 6,162 | 101,919 | 6,162 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | President and Chief ... | Option Exercise | A | 16.54 | 233,836 | 3,867,647 | 233,836 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | President and Chief ... | Option Exercise | A | 16.54 | 6,164 | 101,953 | 6,164 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | A | 16.54 | 35,475 | 586,757 | 35,475 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | VP Finance & CFO | Option Exercise | A | 16.54 | 4,525 | 74,844 | 4,525 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | ELWOOD DWAYNE M | Sr VP Marketing | Option Exercise | A | 16.54 | 35,832 | 592,661 | 35,832 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | ELWOOD DWAYNE M | Sr VP Marketing | Option Exercise | A | 16.54 | 4,168 | 68,939 | 4,168 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | A | 16.54 | 44,434 | 734,938 | 44,434 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | A | 16.54 | 5,566 | 92,062 | 5,566 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | DATA JOANN L | Sr VP Regulatory Af ... | Option Exercise | A | 16.54 | 58,838 | 973,181 | 58,838 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | DATA JOANN L | Sr VP Regulatory Af ... | Option Exercise | A | 16.54 | 6,162 | 101,919 | 6,162 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Option Exercise | A | 16.54 | 20,000 | 330,800 | 40,000 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Chairman of the Boa ... | Option Exercise | A | 16.54 | 20,000 | 330,800 | 20,000 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Option Exercise | A | 16.54 | 46,516 | 769,375 | 46,516 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Option Exercise | A | 16.54 | 18,484 | 305,725 | 18,484 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | A | 16.54 | 58,838 | 973,181 | 58,838 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | A | 16.54 | 6,162 | 101,919 | 6,162 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Option Exercise | A | 16.54 | 103,838 | 1,717,481 | 103,838 | |
May 26 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Option Exercise | A | 16.54 | 6,162 | 101,919 | 6,162 | |
May 11 2005 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Buy | P | 17.35 | 11,500 | 199,525 | 20,345 | 8.8 K to 20.3 K (+130.02 %) |
May 11 2005 | AMLN | AMYLIN PHARMACEUTI ... | ELWOOD DWAYNE M | Sr VP Marketing | Buy | P | 16.70 | 500 | 8,350 | 1,477 | 977 to 1.5 K (+51.18 %) |
May 11 2005 | AMLN | AMYLIN PHARMACEUTI ... | ELWOOD DWAYNE M | Sr VP Marketing | Buy | P | 16.75 | 1,000 | 16,750 | 11,401 | 10.4 K to 11.4 K (+9.61 %) |
May 11 2005 | AMLN | AMYLIN PHARMACEUTI ... | ELWOOD DWAYNE M | Sr VP Marketing | Buy | P | 16.77 | 300 | 5,031 | 10,401 | 10.1 K to 10.4 K (+2.97 %) |
May 11 2005 | AMLN | AMYLIN PHARMACEUTI ... | ELWOOD DWAYNE M | Sr VP Marketing | Buy | P | 16.76 | 1,700 | 28,492 | 10,101 | 8.4 K to 10.1 K (+20.24 %) |
May 10 2005 | AMLN | AMYLIN PHARMACEUTI ... | GREGG TERRANCE H | Director | Buy | P | 16.37 | 3,000 | 49,110 | 8,000 | 5 K to 8 K (+60.00 %) |
May 09 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRYSON VAUGHN D | Director | Buy | P | 16.72 | 20,000 | 334,300 | 126,013 | 106 K to 126 K (+18.87 %) |
May 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 5.73 | 1,750 | 10,028 | 6,977 | |
May 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 5.73 | 1,750 | 10,028 | 8,271 | 6.5 K to 8.3 K (+26.84 %) |
May 06 2005 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | President and Chief ... | Buy | P | 16.65 | 12,000 | 199,800 | 118,535 | 106.5 K to 118.5 K (+11.26 %) |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Option Exercise | M | 9.63 | 3,333 | 32,080 | 0 | |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Option Exercise | M | 9.63 | 3,132 | 30,146 | 3,333 | |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Option Exercise | M | 9.63 | 3,333 | 32,080 | 6,465 | |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Option Exercise | M | 11.95 | 2,709 | 32,373 | 0 | |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Option Exercise | M | 11.13 | 6,250 | 69,531 | 0 | |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Option Exercise | M | 5.73 | 937 | 5,369 | 1,874 | |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Buy | M | 9.63 | 3,333 | 32,080 | 209,395 | 206.1 K to 209.4 K (+1.62 %) |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Buy | M | 5.73 | 937 | 5,369 | 206,062 | 205.1 K to 206.1 K (+0.46 %) |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Buy | M | 9.63 | 3,132 | 30,146 | 205,125 | 202 K to 205.1 K (+1.55 %) |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Buy | M | 9.63 | 3,333 | 32,080 | 201,993 | 198.7 K to 202 K (+1.68 %) |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Buy | M | 11.95 | 2,709 | 32,373 | 198,660 | 196 K to 198.7 K (+1.38 %) |
Apr 29 2005 | AMLN | AMYLIN PHARMACEUTI ... | BROWN MARTIN R | Sr VP Human Resourc ... | Buy | M | 11.13 | 6,250 | 69,531 | 195,951 | 189.7 K to 196 K (+3.29 %) |
Apr 28 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Option Exercise | M | 7.13 | 14,194 | 101,132 | 0 | |
Apr 28 2005 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Buy | M | 7.13 | 14,194 | 101,132 | 41,636 | 27.4 K to 41.6 K (+51.72 %) |
Apr 25 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 933 | 6,706 | 25,849 | |
Apr 25 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 19.00 | 933 | 17,727 | 6,521 | 7.5 K to 6.5 K (-12.52 %) |
Apr 25 2005 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 933 | 6,706 | 7,454 | 6.5 K to 7.5 K (+14.31 %) |